Using Acceptance and Commitment Therapy to help religious OCD

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults (18+) who meet a scrupulosity cutoff will receive Acceptance and Commitment Therapy delivered at the University of Alabama at Birmingham in a single-site, open-label intervention. The study will measure changes in religious OCD symptom severity, feasibility outcomes, and safety using standard symptom scales and clinical interviews. People with recent psychosis, active suicidal intent, recent non-suicidal self-injury, recent narcotics use, or recent purging/restricting behaviors are excluded. The aim is to see whether ACT techniques for acceptance, mindfulness, and values-based action reduce distress and compulsive rituals tied to religious obsessions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years old
* Meet cutoff scores for scrupulosity

Exclusion Criteria:

* Presence of psychotic symptoms within six months of screening
* Current suicidal/homicidal plan/intent and/or a suicide/homicide attempt within 6 months of screening
* Non-suicidal self-injury within 6 months of screening
* Narcotics use within 3 months of screening
* Purging/restricting behavior within 3 months of screening.

Where it's running

• University of Alabama at Birmingham
  Birmingham, Alabama, United States Recruiting

Study contacts

• Study coordinator: David Johnson
• Email: dajohns4@uab.edu
• Phone: 8013891733

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Focused ultrasound for mood and anxiety disorders

  This study tests whether repeated low-intensity focused ultrasound using the ATTN201 device can help people with subsyndromal to moderate depression, anxiety, or OCD.

  Recruiting Attune Neurosciences Inc · San Francisco, California and 1 other locations · NCT07851038

• Predicting Treatment Response in Psychiatric Disorders Using Biological Markers

  This study tests whether biological markers can predict which patients with psychiatric conditions will respond to treatment.

  Recruiting Centre Hospitalier St Anne · Paris · NCT07741981

• Safety and feasibility of a next-generation dome helmet for neuromodulation in OCD

  This study tests whether a new focused ultrasound helmet can safely help people with treatment-refractory OCD see if their symptoms improve.

  Recruiting Sunnybrook Health Sciences Centre · Toronto, Ontario · NCT07704632

• Bergen Four-Day Treatment for OCD, in Finland

  This trial tests whether the Bergen Four-Day Treatment for OCD can be implemented in Finnish psychiatric care to help people with OCD see if the intensive program works in a real-world setting.

  Recruiting Tampere University Hospital · Tampere · NCT07644130

• Test different deep TMS coils and targets to treat OCD

  This study tests whether different deep TMS coils and brain targets help reduce OCD symptoms in adults with OCD, using a double-blind setup with sham and active stimulation.

  Recruiting Taipei Veterans General Hospital, Taiwan · Taipei · NCT07587112

• Role of theta brain waves in how kids control thoughts and actions

  This study tests whether theta-frequency brain activity can reveal how children with ADHD or OCD, and healthy kids, manage thinking and behavior during tasks.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07566468

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.